How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
- 5 May 2020
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 19 (7), 102574
- https://doi.org/10.1016/j.autrev.2020.102574
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative DiseaseJournal of Pediatric Hematology/Oncology, 2016
- Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategiesLupus, 2013
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2011
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesAnnals Of The Rheumatic Diseases, 2010
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology, 2010
- Interferons at age 50: past, current and future impact on biomedicineNature Reviews Drug Discovery, 2007
- Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritisAnnals Of The Rheumatic Diseases, 2007
- How the SARS coronavirus causes disease: host or organism?The Journal of Pathology, 2005
- The Genomes of Oryza sativa: A History of DuplicationsPLoS Biology, 2005
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004